Sydney Julian, III, MD
Associate Clinical Professor
Oral & Maxillofacial Surgery
School of Dentistry

Publications (1)

Top publication keywords:
Bone Density Conservation AgentsMiddle AgedAgedBone ResorptionHumansImidazolesProspective StudiesBone NeoplasmsAged, 80 and overProstatic NeoplasmsDiphosphonatesMale

• Open-label trial evaluating the safety and efficacy of zoledronic acid in preventing bone loss in patients with hormone-sensitive prostate cancer and bone metastases.
  Urology 2005 Polascik TJ, Given RW, Metzger C, Julian SR, Vestal JC, Karlin GS, Barkley CS, Bilhartz DL, McWhorter LT, Lacerna LV